BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14675697)

  • 1. Ovarian conservation and hormone receptors in uterine Müllerian adenosarcomas.
    Tjalma WA
    Gynecol Oncol; 2003 Dec; 91(3):659; author reply 660-1. PubMed ID: 14675697
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistochemical determination of hormone receptors in uterine adenosarcomas.
    Amant F; Gabriel C; Moerman P; Vergote I
    Gynecol Oncol; 2003 Mar; 88(3):463-4. PubMed ID: 12648606
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
    Mikami Y; Hata S; Kiyokawa T; Manabe T
    Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial Stem/Progenitor cell (ES/PC) Marker Expression Profile in Adenosarcoma and Endometrial Stromal Sarcoma.
    Yoon JY; de Kock L; Stewart CJR; McCluggage WG; Foulkes WD; Clarke BA; Rouzbahman M
    Cancer Treat Res Commun; 2021; 27():100363. PubMed ID: 33838572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.
    Amant F; Schurmans K; Steenkiste E; Verbist L; Abeler VM; Tulunay G; De Jonge E; Massuger L; Moerman P; Vergote I
    Gynecol Oncol; 2004 Jun; 93(3):680-5. PubMed ID: 15196864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian conservation in a woman of reproductive age with müllerian adenosarcoma.
    Michener CM; Simon NL
    Gynecol Oncol; 2001 Nov; 83(2):424-7. PubMed ID: 11606111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correspondence re: Mikami Y, Hata S, Kiyokawa T, Manabe T. Expression of CD10 in malignant mullerian mixed tumors and adenosarcomas: an immunohistochemical study. Mod pathol 2002;15:923-30.
    Zamecnik M
    Mod Pathol; 2003 Jun; 16(6):618-9; author reply 619. PubMed ID: 12808069
    [No Abstract]   [Full Text] [Related]  

  • 8. Female Sex Hormone Receptor Profiling in Uterine Adenosarcomas.
    Marcus JZ; Klobocista M; Karabakhtsian RG; Prossnitz E; Goldberg GL; Huang GS
    Int J Gynecol Cancer; 2018 Mar; 28(3):500-504. PubMed ID: 29303935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD10, estrogen and progesterone receptor expression in ovarian adenosarcoma.
    Van Mieghem T; Abeler VM; Moerman P; Verbist L; Vergote I; Amant F
    Gynecol Oncol; 2005 Nov; 99(2):493-6. PubMed ID: 16051333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosarcoma of the uterine corpus associated with ovarian thecoma.
    Nomura K; Aizawa S; Ushigome S
    Pathol Int; 2001 Sep; 51(9):735-8. PubMed ID: 11696179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cluster of uterine mullerian adenosarcoma in the Washington, DC metropolitan area with high incidence of sarcomatous overgrowth.
    Seidman JD; Wasserman CS; Aye LM; MacKoul PJ; O'Leary TJ
    Am J Surg Pathol; 1999 Jul; 23(7):809-14. PubMed ID: 10403304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine Adenosarcoma.
    Pinto A; Howitt B
    Arch Pathol Lab Med; 2016 Mar; 140(3):286-90. PubMed ID: 26927725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma.
    Gallardo A; Prat J
    Am J Surg Pathol; 2009 Feb; 33(2):278-88. PubMed ID: 18941402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Local uterine hormonemia and steroid hormone receptors].
    Savitskiĭ GA; Savchenko ON; Sekretareva EV; Usova AA; Svechnikova FA
    Akush Ginekol (Mosk); 1985 Feb; (2):19-22. PubMed ID: 3158222
    [No Abstract]   [Full Text] [Related]  

  • 15. Surgical conservation of both ovaries in an adolescent with uterine müllerian adenosarcoma: a case report.
    Ozmen B; Uzum N; Unlu C; Ortac F; Ataoglu O
    J Minim Invasive Gynecol; 2007; 14(3):375-8. PubMed ID: 17478375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognosis-related clinicopathologic characteristics of FIGO stage Ⅰ Müllerian adenosarcoma of uterus].
    Wang Y; Liu AJ; Chen X; Song X
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):334-338. PubMed ID: 29783798
    [No Abstract]   [Full Text] [Related]  

  • 17. [Steroid hormone receptors in normal uterine endometrium and uterine adenocarcinoma of human subjects (author's transl)].
    Nioka S
    Nihon Naibunpi Gakkai Zasshi; 1978 Feb; 54(2):158-73. PubMed ID: 640096
    [No Abstract]   [Full Text] [Related]  

  • 18. Two unusual presentations of müllerian adenosarcoma: case reports, literature review, and treatment considerations.
    Gollard R; Kosty M; Bordin G; Wax A; Lacey C
    Gynecol Oncol; 1995 Dec; 59(3):412-22. PubMed ID: 8522267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and progesterone receptors in vaginal and uterine adenocarcinomas following estrogen use.
    Eisenfeld AJ; Schwartz PE; Morris JM
    Gynecol Oncol; 1980 Aug; 10(1):63-8. PubMed ID: 7399330
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathology of mixed Müllerian tumours.
    D'Angelo E; Prat J
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):705-18. PubMed ID: 21742560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.